Programme
(Preliminary)
Wednesday June 11th - Presymposium
|
08:30 - 09:45
|
Registration for presymposium and entire congress
|
|
09:45 - 10:00
|
Welcome
|
|
10:00 - 11:00
|
Norway
Amyloidosis in a nephrological perspective | Dr. Tale Wien, Bærum Who is the patient with amyloidosis? Characteristics and epidemiology | Dr. Hilde Vasstrand, Bærum AA-amyloidosis in peaople who inject drugs | Dr. Helga Gudmundsdottir, Oslo |
|
11:00 - 11:10
|
Break
|
|
11:10 - 12:10
|
Denmark
CVD in CKD
|
|
12:10 - 12:20
|
Break
|
|
12:20 - 13:20
|
Sweden
Different aspects on contributing mechanisms in ANCA-associated vasculitis
|
|
13:20 - 14:50
|
Lunch break
|
|
13:45 - 14:45
|
Lunch symposium - sponsored by Novo Nordisk (Gold sponsor)
Metabolic and Renal Interplay: Exploring Obesity, Diabetes, and Chronic Kidney Disease Interconnected Metabolic Pathways: Obesity, Diabetes, and Chronic Kidney Disease Revolutionizing Metabolic Nephropathy Management: The Emergence of GLP-1 Receptor Agonists |
|
14:50 - 15:50
|
Iceland
|
|
15:50 - 16:00
|
Break
|
|
16:00 - 17:00
|
Finland
|
|
17:00 - 17:15
|
Break
|
|
17:15 - 17:25
|
NSN Congress Opening
|
|
17:25 - 17:45
|
Best abstract
|
Thursday June 12th - Congress
|
08:30 - 09:30
|
Expert panel discussion: Early CKD detection, prevention and referral | Prof. Bård Waldum Grevbo, Oslo, Prof. Maria Eriksson Svensson, Uppsala and Prof. Peter Rossing, Copenhagen
|
|
09:30 - 09:45
|
Break
|
|
Chairs: Dr. Marit Dahl Solbu, Tromsø and Dr. Lene V. Halvorsen, Oslo
|
|
|
09:45 - 10:45
|
Antihypertensive treatment in CKD | Docent Daniel Gordin, Helsinki
Hypertension in Pregnancy | Prof. Jana Brguljan Hitij, Ljubljana |
|
10:45 - 11:00
|
Break
|
|
11:00 - 12:05
|
State of the art 1
Quality of life for elderly on dialysis therapy | Prof. Edwina Brown, London |
|
12:05 - 12:30
|
Break
|
|
|
Chairs: Dr. Helga Gudmundsdottir, Oslo
|
|
12:30 - 13:30
|
Lunch symposium - sponsored by Vantive (Platinum sponsor)
Extending Lives Expanding Possibilities PD cases: You decide - Experts guide. Chairman: Helga Gudmundsdottir, Nephrologist at OUS, Ullevål. Norway Treating patients with PD allows for increased freedom for life compared to HD. Modern PD is beneficial for patient outcomes and healthcare costs, while introduction of remote patient management systems has enabled safer treatment in patients’ homes. Join our session to hear how leading Nordic nephrologists in PD care see the challenges, and how they would overcome them with evidence based solutions. |
|
13:30 - 13:40
|
Break
|
|
13:40 - 14:40
|
Debunking the myths of PD | Dr. Stig Arne Kjellevold, Tønsberg
Maintaining a high prevalence of patients in PD | Dr. Helga Gudmundsdottir, Oslo Peritoneal dialysis in children | TBD |
|
14:40 - 14:50
|
Break
|
|
14:50 - 16:05
|
Poster Session
|
|
16:05 - 16:30
|
Break
|
|
16:30 - 17:30
|
Industry symposium sponsored by Astra Zeneca (Platinum Sponsor)
Title TBD |
|
17:30 - 17:40
|
Break
|
|
17:40 - 18:00
|
Best abstract
|
|
19:00 - 21:00
|
Get Together Oslo City Hall (Rådhuset)
|
Friday June 13th - Congress
|
Chairs: Prof. Ilkka Helanterä and Dr. Kristian Heldal
|
|
|
08:30 - 09:15
|
Pro’s and Con’s of Cardiovascular Screening before Kidney Transplantation | Assoc. Prof. Simon Winther, Aarhus
Cardiorenal Prophylaxis After Kidney Transplantation | Prof. Trond Jenssen, Oslo |
|
09:15 - 09:30
|
Break
|
|
Chairs: Prof. Susanne Dam Poulsen and Dr. Karsten Midtvedt
|
|
|
09:30 - 10:45
|
Vaccination of Solid Organ Transplant Candidates and Recipients – Experiences from a Structured Vaccination Clinic | Prof. Susanne Dam Poulsen, Copenhagen
New Guidelines and New Treatments – Update on CMV and BKV after Kidney Transplantation | Prof. Ilkka Helanterä, Helsinki Coping with EBV and Risk of PTLD - Recent Insights | Dr. Lene Ugilt Pagter Ludvigsen, Aarhus |
|
10:45 - 11:10
|
Break
|
|
Chairs Prof. Trond Jenssen and Prof. Kåre Birkeland
|
|
|
11:10 - 12:00
|
State-of-the-Art for Beta-Cell Replacement in Type 1 Diabetes: Stem Cell-Derived Islets and/or Gene-Modified Islet Cells Without the Need for Immunosuppression | Prof. Per Ola Carlsson, Uppsala
|
|
12:00 - 12:30
|
Break
|
|
12:30 - 13:30
|
Lunch symposium - sponsored by CSL Vifor (Platinum sponsor)
What is the role of the complement system in ANCA-associated vasculitis? | Associate professor Sophie Ohlsson, Lund University New therapeutic options in IgAN – a clinical perspective | Professor Adrian Schreiber, Charité, University Hospital Berlin |
|
13:30 - 13:40
|
Break
|
|
13:40 - 14:40
|
CKD MBD: The spectrum of bone diseases in chronic kidney disease | Assoc. Prof. Hanne Mari Skov Jørgensen, Aarhus
CKD MBD: Preventing fractures in patients with CKD | Prof. Syazrah Salam, Sheffield |
|
14:40 - 14:50
|
Break
|
|
14:50 - 16:05
|
Poster Session
|
|
16:05 - 16:30
|
Break
|
|
16:30 - 17:30
|
Industry symposium - sponsored by Boehringer Ingelheim (Gold Sponsor)
Title TBD |
|
17:30 - 17:40
|
Break
|
|
17:40 - 18:00
|
Best abstract 2
|
|
19:00 -
|
Congress dinner
|
Saturday June 14th - Congress
|
09:00 - 10:30
|
State of the art 3 and plenary discussion
Immunosuppressive therapy in IgA nephritis | Jonathan Barratt and Yngvar Haaskjold Setting the Scene and Current Goals in IgA Nephropathy | Jonathan Barratt Prognostic Models in IgA Nephropathy | Yngvar Haaskjold Immunosuppressive Treatments in IgA Nephropathy: When, Which, and Duration? | Jonathan Barratt IgA Vasculitis: Similarities and Contrasts with IgA Nephropathy | Jonathan Barratt |
|
10:30 - 10:40
|
Break
|
|
10:40 - 11:50
|
Advanced molecular profiling of FFPE kidney tissues | Øystein Eikrem
MPGN and C3 | Kati Kaartinen CAR-T cell theraphy in immune-mediated kidney diseases: future prospects an safety | Yngvar Haaskjold |
|
11:50- 12:05
|
Break
|
|
12:05 - 13:05
|
Lunch symposium - sponsored by Medice Nordic (Gold sponsor)
Vadadustat INNO2VATIVE anaemia management for dialysis patients |
|
13:05 - 13:15
|
Congress conclusion
|